Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, inaugurated its new facility at the Colmar site in France. The new Innovaform Accelerator will serve as a Center of Excellence for developing and innovating capsule-based manufacturing and delivery solutions for oral and pulmonary administration.    While oral administration of active pharmaceutical ingredients (APIs) is the preferred route of administration, most new entities face solubility and bi...